Medtech InsightThe top 100 publicly listed and reportable medical technology companies had global sales spanning from more than $30bn to some $100m in the lower reaches, according to the most recent year of fully re
Medtech InsightBreast cancer is the leading cancer in women globally and incidences continue to rise. To reverse this trend, several companies are focusing their efforts on developing imaging technologies that allow
In VivoDevice Transactions Device fundraising in Q4 2017 totaled $2.6 billion, the highest single-quarter value of the year. However, total 2017 financing for the industry declined from 2016: $8.4 billion in
In VivoFDA product reviews were the lead story for the year, as Class II device designations emerged for large-panel tumor-profiling assays and direct-to-consumer (DTC) genetic health risk assessment (GHRA)